NASDAQ:BLPH

Bellerophon Therapeutics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.0625

+0 (+0%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for BLPH

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	0.0625	.
		R2	0.0625	.
		R1	0.0625	.
Current price:			0.0625
	Support	S1	0.0625	.
		S2	0.0625	.
		S3	0.0625	.

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0	.
		R2	0.0650	4.00 %
		R1	0.0640	2.40 %
Current price			0.0625
	Support	S1	0.0550	-12.00%
		S2	0.0533	-14.80%
		S3	0.0510	-18.40%

BLPH Predictions History

7 years ago
JS predicted that BLPH for 2017-02-15 is going $1.06 (17.78%)

7 years ago
Drafrago predicted that BLPH for 2017-02-15 is going $1.07 (18.89%)

Rank:

7 years ago
Ron.Boutwell.1883 predicted that BLPH for 2017-02-15 is going $1.05 (2.94%)

Rank:

7 years ago
JS predicted that BLPH for 2017-02-13 is going $0.728 (-1.62%)

7 years ago
PeteKTF predicted that BLPH for 2017-02-13 is going $0.670 (-9.46%)

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In